Skip to content

Clinical observation of Rexianbao combined with Jinhuang ointment in the treatment of chronic mastitis mass

Clinical observation of Rexianbao combined with Jinhuang ointment in the treatment of chronic mastitis mass

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047029
Enrollment
Unknown
Registered
2021-06-07
Start date
2021-06-08
Completion date
Unknown
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic mastitis

Interventions

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 60 years; 2. Accorded with the diagnostic criteria of non-lactation mastitis; 3. Meet the above clinical staging criteria (patients with breast masses); 4. Be willing to accept the hot election package treatment and sign the informed consent form. 5. The patients with non-lactation mastitis who were included in the study did not use other topical drugs during the study.

Exclusion criteria

Exclusion criteria: 1. Complicated with severe liver and kidney damage, primary diseases of immune system, hematopoietic system diseases, endocrine or other diseases, serious diseases; 2. Participating in other clinical trials; 3. Long-term use of hormones or immunosuppressants or other drugs that affect the observation of the curative effect; 4. The patient has allergic constitution or history of drug allergy.

Design outcomes

Primary

MeasureTime frame
Lump size;

Countries

China

Contacts

Public ContactXia Zhongyuan

China-Japan Friendship Hospital

2718421708@qq.com+86 13701338757

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026